Autism and ABA Therapy M&A Market Intelligence Report: The PGP Perspective | 2026-2027

The Autism and ABA Therapy sector has transitioned from a fragmented, high-growth phase into a mature, quality-driven market where clinical outcomes, operational efficiency, and geographic density now dictate valuation. While the initial rush of the early 2020s has subsided, the current cycle offers significant value for well-run independent practices that can navigate labor constraints and evolving payor requirements through accretive technology and clinical arbitrage.

Owning an independent Applied Behavior Analysis (ABA) practice in 2026 requires operating in the middle of a large supply-demand imbalance that continues to intensify. As diagnosis rates rise and insurance mandates stabilize, the market is no longer solely looking for clinic hours – it is hunting for sophisticated practices capable of delivering measurable outcomes at scale. For the independent owner, this presents a unique window of opportunity where the scarcity of high-quality, mid-market assets has created a seller’s market for established practices with robust BCBA retention and diversified payor mix. This report is designed to provide the perspective necessary for an owner to evaluate a potential partnership or liquidity event with confidence and make an informed decision.

The $5+ billion U.S. Autism and ABA Therapy sector is part of a broader global autism treatment market projected to reach $18+ billion by 2034, with a CAGR of 9%. North America continues to dominate the global market, accounting for nearly 60% of total revenue due to widespread diagnostic penetration and legislative support. In the U.S., the continued expansion of clinic-based services has revolutionized the treatment delivery system, yet the market remains characterized by low concentration and high fragmentation. ¹,²

The key dynamic of 2026 is finding the right balance between clinical and operational quality and geographic density. While there is an abundance of small, lifestyle-oriented practices, there is a severe shortage of mid-to-large platforms that have successfully integrated AI-driven clinical documentation and outcome-optimization infrastructures. For the independent operator, this creates a significant arbitrage opportunity: by professionalizing back-office functions and stabilizing the clinical workforce, an independent practice becomes a highly sought-after add-on asset for PE-backed platforms looking to build geographic density.

The market has moved past the era of ‘growth at all costs.’ Today, the most accretive outcomes are reserved for platforms that can demonstrate clinical rigor alongside operational efficiency, turning the BCBA shortage from a headwind into a competitive moat.

Valuation in 2026 is anchored by the “flight to quality.” While overall healthcare M&A has seen a recalibration, transaction multiples for high-performing behavioral health assets have remained resilient. A reference point for the current cycle is the acquisition of Ally Pediatric Therapy (previously owned by SBJ Capital) by ACES ABA (owned by large cap PE firm General Atlantic) in January 2026. While specific multiples for that transaction were not disclosed, current market data suggests that platforms with $5M+ in EBITDA can command multiples in the 8x–12x+ range, while smaller, add-on practices ($500k–$2M EBITDA) typically see 5x–8x multiples. ³

Recent activity highlights that buyers are willing to pay a premium for multidisciplinary integration. Platforms that combine ABA with speech, occupational, and feeding therapies – creating a “one-stop” clinical setting – are achieving higher valuations than peers limited solely to professional ABA fees.

The buyer universe in 2026 is stratified into distinct categories, each with a different investment thesis:

• Large-Scale PE-Backed Platforms: Entities like ACES ABA (General Atlantic), Action Behavior Centers (Charlesbank Capital), Behavioral Innovations (Tenex), Caravel Autism Health (GTCR), Hopebridge (Arsenal Capital), and LEARN Behavioral (Gryphon Investors) are pursuing add-on strategies to build out density in current and new markets. Their focus is on accretive acquisitions that allow for immediate synergies.
• Small- and Mid-Sized PE-Backed Platforms: Small- and mid-sized entities are focused on M&A and de novo opportunities to build additional scale. They are also looking to expand service lines, enhance localized density and payor relationships, and invest in technology and AI to optimize labor.
• Thesis-Specific Private Equity: New entrants, such as Acquitaine Capital (who acquired KidsChoice in Oklahoma), are targeting the lower-middle market with a “clinical-first” focus, often acquiring platforms in states with favorable Medicaid rate updates (e.g., Oklahoma, Illinois).
• Franchise & Consolidator Models: Brands like Success on the Spectrum are expanding through a decentralized franchise model, targeting founder-owners who want to maintain local branding while leveraging a larger corporate infrastructure.

• Valuation Multiples: Private market M&A has entered a “stability tier,” where predictable reimbursement and high demand keep multiples at attractive levels; a dynamic expected to hold through 2026.
• Technological Displacement Risk: The cost of staying independent is rising as AI-driven documentation and “outcome-optimization” platforms become the standard for payor contracting. Owners must choose between a heavy capital investment in tech or a partnership with a platform that has already scaled these solutions.
• Record Private Equity Dry Powder: Financial sponsors have substantial uncommitted capital specifically allocated to drive growth in key sectors.
• Succession and Liquidity Optionality: Many owners who built their practices during the 2014-2018 insurance mandate wave are now seeking avenues to monetize their business. A recapitalization allows owners to “take chips off the table” while retaining equity in a larger, diversified entity.

Recent regulatory and reimbursement shifts have fortified the financial foundation of the ABA sector. In Illinois, House Bill 2428 has mandated a 3.5% Medicaid rate increase effective January 1, 2026, specifically for ABA services, ensuring continued financial viability for practices. ⁴ Medicaid spending on ABA therapy in North Carolina has increased from $100+ million in 2022 to a projected $600+ million in 2026. ⁵

Furthermore, the February 2026 release of the CMS Medicaid Managed Care Rate Development Guide suggests a continued focus on actuarial soundness for behavioral health services, which supports steady capitation rates through the 2026-2027 cycle. These tailwinds, combined with the structural shortage of BCBAs, create a stable foundation with growth upside for established providers who are operating in a compliant manner and can maintain clinical staffing.

The Autism and ABA Therapy sector has entered a critical phase of its evolution. Several first-generation PE-backed platforms are nearing the end of their typical hold periods, which will likely trigger a new wave of secondary buyouts and platform consolidations throughout 2026. This creates an interesting environment for independent practices that can serve as “tuck-in” acquisitions or secondary platforms.

PGP views the current environment as particularly favorable for owners who have successfully managed the transition from purely home-based to clinic-centric or multidisciplinary models. The market is currently placing a significant premium on margin consistency and clinician retention metrics. For the independent operator, this competitive tension between large strategics and growth-oriented PE sponsors often leads to more favorable deal structures, including higher upfront cash components and more robust “rollover” equity opportunities.